Valor20242025Total de passivos79.65 M111.94 MCapital total28.42 M9.46 MTotal de passivos e patrimônio líquido108.08 M121.4 MDívida total30.16 M30.59 MDívida líquida-37.3 M-50.95 M
Fractyl Health, Inc. - Common Stock
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1.